A national survey of primary care physicians' colorectal cancer screening recommendations and practices

被引:187
作者
Klabunde, CN
Frame, PS
Meadow, A
Jones, E
Nadel, M
Vernon, SW
机构
[1] NCI, Hlth Serv, Appl Res Program, Bethesda, MD 20892 USA
[2] NCI, Econ Branch, Appl Res Program, Bethesda, MD 20892 USA
[3] Univ Rochester, Sch Med & Dent, Dept Family Med, Rochester, NY USA
[4] Tri Cty Family Med, New York, NY USA
[5] Ctr Medicare, Off Res Dev & Informat, Baltimore, MD USA
[6] Medicaid Serv, Baltimore, MD USA
[7] Natl Inst Hlth, Ctr Clin, Dept Diagnost Radiol, Bethesda, MD USA
[8] Ctr Dis Control & Prevent, Div Canc Prevent & Control, Atlanta, GA USA
[9] Univ Texas, Hlth Sci Ctr, Sch Publ Hlth, Houston, TX USA
关键词
colorectal cancer; screening; primary care; health services delivery;
D O I
10.1016/S0091-7435(02)00066-X
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. National data on providers' colorectal cancer (CRC) screening knowledge, attitudes, and practices are sparse. This study assessed primary care physicians' (PCPs') beliefs about the effectiveness of CRC screening, their recommendations for screening, their perceptions of the influence of published guidelines on their CRC screening recommendations, and how they conduct CRC screening in their clinical practices. Methods. A questionnaire was administered to a nationally representative sample of practicing PCPs. Of 1718 eligible physicians, 1235 (72%) responded. Results. Only 2% of PCPs said they did not recommend CRC screening. Over 80% indicated that they most often recommend CRC screening with fecal occult blood testing and/or flexible sigmoidoscopy, although colonoscopy was perceived as the more effective screening modality. Nearly two-thirds of obstetrician/gynecologists and one-fourth of other practitioners reported conducting fecal occult blood testing exclusively by digital rectal exam. Only 29% of PCPs said they perform sigmoidoscopy. Estimated volumes of ordering, performing, or referring for CRC screening were low, and <20% reported that three-fourths or more of their older patients were up to date with CRC screening as recommended by the physician. Many PCPs reported recommending CRC screening at nonstandard starting ages or too-frequent intervals. Conclusions. Awareness of CRC screening among PCPs in the United States is high. However, knowledge gaps about the timing and frequency of screening and suboptimal screening delivery were evident. (C) 2003 American Health Foundation and Elsevier Science (USA). All rights reserved.
引用
收藏
页码:352 / 362
页数:11
相关论文
共 54 条
[1]  
*AM AC FAM PHYS, PER HLTH EX SUMM AAF
[2]  
*AM COLL OBST GYN, REV REC COL CANC SCR
[3]  
*AM COLL PHYS AM S, SCREEN BREAST COL PR
[4]   HAS THE USE OF CERVICAL, BREAST, AND COLORECTAL-CANCER SCREENING INCREASED IN THE UNITED-STATES [J].
ANDERSON, LM ;
MAY, DS .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1995, 85 (06) :840-842
[5]   American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: Update 1997 [J].
Byers, T ;
Levin, B ;
Rothenberger, D ;
Dodd, GD ;
Smith, RA .
CA-A CANCER JOURNAL FOR CLINICIANS, 1997, 47 (03) :154-&
[6]   Why don't physicians follow clinical practice guidelines? A framewouk for improvement [J].
Cabana, MD ;
Rand, CS ;
Powe, NR ;
Wu, AW ;
Wilson, MH ;
Abboud, PAC ;
Rubin, HR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (15) :1458-1465
[7]   Licensure, use, and training of paramedical personnel to perform screening flexible sigmoidoscopy [J].
Cash, BD ;
Schoenfeld, PS ;
Ransohoff, DF .
GASTROINTESTINAL ENDOSCOPY, 1999, 49 (02) :163-169
[8]   A SURVEY OF PHYSICIAN BELIEFS AND SELF-REPORTED PRACTICES CONCERNING SCREENING FOR EARLY DETECTION OF CANCER [J].
CLASEN, CM ;
VERNON, SW ;
MULLEN, PD ;
JACKSON, GL .
SOCIAL SCIENCE & MEDICINE, 1994, 39 (06) :841-849
[9]   Primary care physician recommendations for colorectal cancer screening - Patient and practitioner factors [J].
Cooper, GS ;
Fortinsky, RH ;
Hapke, R ;
Landefeld, CS .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (17) :1946-1950
[10]  
Cooper GS, 1998, CANCER, V82, P1476, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1476::AID-CNCR7>3.0.CO